2.04
price up icon0.49%   0.01
after-market Handel nachbörslich: 2.04
loading
Schlusskurs vom Vortag:
$2.03
Offen:
$2.0856
24-Stunden-Volumen:
25,983
Relative Volume:
1.30
Marktkapitalisierung:
$13.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.72M
KGV:
-0.7729
EPS:
-2.6394
Netto-Cashflow:
$-6.25M
1W Leistung:
+1.75%
1M Leistung:
+2.51%
6M Leistung:
+7.05%
1J Leistung:
-51.54%
1-Tages-Spanne:
Value
$2.035
$2.11
1-Wochen-Bereich:
Value
$1.91
$2.14
52-Wochen-Spanne:
Value
$1.55
$5.59

Edesa Biotech Inc Stock (EDSA) Company Profile

Name
Firmenname
Edesa Biotech Inc
Name
Telefon
(905) 475-1234
Name
Adresse
100 SPY COURT, MARKHAM, ON
Name
Mitarbeiter
16
Name
Twitter
@EdesaBiotech
Name
Nächster Verdiensttermin
2024-08-12
Name
Neueste SEC-Einreichungen
Name
EDSA's Discussions on Twitter

Vergleichen Sie EDSA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
EDSA
Edesa Biotech Inc
2.04 13.34M 0 -7.72M -6.25M -2.6394
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Edesa Biotech Inc Aktie (EDSA) Neueste Nachrichten

pulisher
Jun 11, 2025

Edesa Biotech secures up to C$23 million in funding under the Federal Government’s Strategic Innovation Fund for pivotal clinical study - Fasken

Jun 11, 2025
pulisher
Jun 11, 2025

Edesa Biotech, Inc. closes US$10 million bought deal offering of common shares - Fasken

Jun 11, 2025
pulisher
Jun 11, 2025

40,944 Shares in Edesa Biotech, Inc. (NASDAQ:EDSA) Bought by Citadel Advisors LLC - Defense World

Jun 11, 2025
pulisher
May 28, 2025

Edesa Biotech Shareholders Approve Key Proposals at AGM - TipRanks

May 28, 2025
pulisher
May 23, 2025

Edesa Biotech (EDSA) Receives Buy Rating from Lucid Capital | ED - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Zacks Small Cap Reduces Earnings Estimates for Edesa Biotech - Defense World

May 23, 2025
pulisher
May 19, 2025

EDSA: Advancing EB06 for the Treatment of Vitiligo - Research Tree

May 19, 2025
pulisher
May 19, 2025

EDSA: Advancing EB06 for the Treatment of Vitiligo… - Yahoo Finance

May 19, 2025
pulisher
May 18, 2025

Positive Signs As Multiple Insiders Buy Edesa Biotech Stock - Yahoo Finance

May 18, 2025
pulisher
May 15, 2025

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results - GlobeNewswire

May 15, 2025
pulisher
May 14, 2025

Edesa Biotech Shifts Focus to Vitiligo Treatment in Q2 2025 - TipRanks

May 14, 2025
pulisher
May 14, 2025

Edesa Biotech Q2 EPS USD -0.3 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Edesa Biotech Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

Edesa Biotech Reports Q2 2025 Financial Results and Advances Vitiligo Drug Development Efforts - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Edesa Biotech Advances Novel Vitiligo Treatment with $15M Backing from Healthcare Investors - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Edesa Biotech Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView

May 13, 2025
pulisher
May 02, 2025

Edesa Biotech (EDSA) to Release Quarterly Earnings on Friday - Defense World

May 02, 2025
pulisher
Apr 28, 2025

Edesa Biotech to Present at 2024 Bloom Burton Healthcare Investor Conference - TipRanks

Apr 28, 2025
pulisher
Apr 28, 2025

Edesa Biotech to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference in Toronto - Nasdaq

Apr 28, 2025
pulisher
Apr 28, 2025

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference - GlobeNewswire

Apr 28, 2025
pulisher
Apr 28, 2025

Edesa Biotech Showcases Immuno-Inflammatory Pipeline at Bloom Burton Healthcare Conference - Stock Titan

Apr 28, 2025
pulisher
Apr 24, 2025

Edesa Biotech (NASDAQ:EDSA) Shares Up 3% – Time to Buy? - Defense World

Apr 24, 2025
pulisher
Apr 15, 2025

Healthcare Veteran Returns to NeuPath as President, Armed with Ambitious Expansion Plan - Stock Titan

Apr 15, 2025
pulisher
Apr 13, 2025

Edesa Biotech secures $15 million for clinical program - MSN

Apr 13, 2025
pulisher
Apr 05, 2025

Edesa Biotech (NASDAQ:EDSA) and Earth Science Tech (OTCMKTS:ETST) Head-To-Head Review - Defense World

Apr 05, 2025
pulisher
Apr 05, 2025

Edesa Biotech says Peter Weiler to succeed Stephen Lemieux as CFO - MSN

Apr 05, 2025
pulisher
Apr 05, 2025

Nuvectis Pharma (NASDAQ:NVCT) and Edesa Biotech (NASDAQ:EDSA) Critical Analysis - Defense World

Apr 05, 2025
pulisher
Apr 05, 2025

Edesa Biotech Announces Chief Financial Officer Transition - GlobeNewswire

Apr 05, 2025
pulisher
Apr 04, 2025

Edesa Biotech announces CFO transition - MSN

Apr 04, 2025
pulisher
Apr 04, 2025

Edesa Biotech names Peter Weiler as new CFO By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Edesa Biotech (EDSA) Shares Drop After New CFO Announcement - GuruFocus

Apr 04, 2025
pulisher
Apr 04, 2025

Edesa Biotech Appoints New CFO Amid Leadership Change - TipRanks

Apr 04, 2025
pulisher
Apr 04, 2025

Edesa Biotech names Peter Weiler as new CFO - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

Edesa Biotech Hires Peter Weiler From Exzell Pharma to be New CFO - marketscreener.com

Apr 04, 2025
pulisher
Apr 04, 2025

Edesa Biotech, Inc. Announces Chief Financial Officer Changes, Effective May 1, 2025 - MarketScreener

Apr 04, 2025
pulisher
Mar 17, 2025

HC Wainwright Comments on Edesa Biotech Q2 Earnings - Defense World

Mar 17, 2025
pulisher
Mar 15, 2025

HC Wainwright Reiterates “Buy” Rating for Edesa Biotech (NASDAQ:EDSA) - Defense World

Mar 15, 2025
pulisher
Mar 13, 2025

H.C. Wainwright maintains $21 target on Edesa Biotech shares By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

H.C. Wainwright maintains $21 target on Edesa Biotech shares - Investing.com India

Mar 13, 2025
pulisher
Mar 11, 2025

Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential - The Globe and Mail

Mar 11, 2025
pulisher
Mar 07, 2025

Edesa Biotech completes US$15 million private placement - Fasken

Mar 07, 2025
pulisher
Mar 07, 2025

You Won't Believe What Nvidia CEO Jensen Huang Just Said - The Globe and Mail

Mar 07, 2025
pulisher
Mar 06, 2025

Edesa Biotech files to sell 7.81M common shares for holders - MSN

Mar 06, 2025
pulisher
Mar 06, 2025

Nvidia Stock Isn’t So Magnificent Anymore. Is It Time to Sell Shares Now? - The Globe and Mail

Mar 06, 2025
pulisher
Mar 06, 2025

Zacks Small Cap Boosts Earnings Estimates for Edesa Biotech - Defense World

Mar 06, 2025
pulisher
Mar 03, 2025

EDSA: Raises 15 Million to Advance EB06 - Smartkarma

Mar 03, 2025
pulisher
Mar 03, 2025

EDSA: Raises $15 Million to Advance EB06… - Yahoo Finance

Mar 03, 2025
pulisher
Feb 17, 2025

Biotech Stocks To Keep An Eye OnFebruary 13th - MarketBeat

Feb 17, 2025
pulisher
Feb 15, 2025

Biotech Stocks To Keep An Eye On – February 13th - Defense World

Feb 15, 2025

Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):